» Articles » PMID: 33436560

CircNDUFB2 Inhibits Non-small Cell Lung Cancer Progression Via Destabilizing IGF2BPs and Activating Anti-tumor Immunity

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Jan 13
PMID 33436560
Citations 278
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNA) are a class of covalently closed single-stranded RNAs that have been implicated in cancer progression. Here we identify circNDUFB2 to be downregulated in non-small cell lung cancer (NSCLC) tissues, and to negatively correlate with NSCLC malignant features. Elevated circNDUFB2 inhibits growth and metastasis of NSCLC cells. Mechanistically, circNDUFB2 functions as a scaffold to enhance the interaction between TRIM25 and IGF2BPs, a positive regulator of tumor progression and metastasis. This TRIM25/circNDUFB2/IGF2BPs ternary complex facilitates ubiquitination and degradation of IGF2BPs, with this effect enhanced by N-methyladenosine (mA) modification of circNDUFB2. Moreover, circNDUFB2 is also recognized by RIG-I to activate RIG-I-MAVS signaling cascades and recruit immune cells into the tumor microenvironment (TME). Our data thus provide evidences that circNDUFB2 participates in the degradation of IGF2BPs and activation of anti-tumor immunity during NSCLC progression via the modulation of both protein ubiquitination and degradation, as well as cellular immune responses.

Citing Articles

circZNF707 promoted glycolysis and tumor progression through miR-668-3p-PFKM axis in NSCLC.

Chen W, Fang S, Wu X, Fang T, Chen Z, Su W Eur J Med Res. 2025; 30(1):141.

PMID: 40016838 PMC: 11866724. DOI: 10.1186/s40001-025-02359-z.


circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLC.

Chen W, Zhao W, Wu X, Fang T, Chen Z, Chen Z Cancer Med. 2025; 14(5):e70729.

PMID: 40013670 PMC: 11866311. DOI: 10.1002/cam4.70729.


EIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via Wnt/β-catenin pathway.

Fang Z, Wu Z, Yu C, Xie Q, Zeng L, Chen R Mol Cancer. 2025; 24(1):56.

PMID: 40001070 PMC: 11863466. DOI: 10.1186/s12943-025-02262-5.


Identification of IGF2BPs-related mRNA signature for predicting the overall survival of lung adenocarcinoma.

Xu X, Zhao W, Peng D, Sun Y, Tantai J, Zhao G Sci Rep. 2025; 15(1):5681.

PMID: 39956818 PMC: 11830784. DOI: 10.1038/s41598-025-87874-z.


CircPRMT5, a Potential Salivary Biomarker, Facilitates the Progression of Head and Neck Squamous Cell Carcinoma via the IGF2BP3-SERPINE1 Pathway.

Jiang S, Ou L, Wang Y, Su K, Chen Z, He L Int J Nanomedicine. 2025; 20:1597-1613.

PMID: 39931528 PMC: 11807777. DOI: 10.2147/IJN.S502400.


References
1.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

2.
Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View

3.
Reck M, Heigener D, Mok T, Soria J, Rabe K . Management of non-small-cell lung cancer: recent developments. Lancet. 2013; 382(9893):709-19. DOI: 10.1016/S0140-6736(13)61502-0. View

4.
Hirsch F, Scagliotti G, Mulshine J, Kwon R, Curran Jr W, Wu Y . Lung cancer: current therapies and new targeted treatments. Lancet. 2016; 389(10066):299-311. DOI: 10.1016/S0140-6736(16)30958-8. View

5.
Li X, Yang L, Chen L . The Biogenesis, Functions, and Challenges of Circular RNAs. Mol Cell. 2018; 71(3):428-442. DOI: 10.1016/j.molcel.2018.06.034. View